The Use of Glipizide Combined with Intensive Insulin Treatment for the Induction of Remissions in New Onset Adult Type I Diabetes

References

• Feutren G, Assan R, Karsenty G. Cyclosporin Increases the Rate and Length of Remissions in Insulin-Dependent Diabetes of Recent Onset. Lancet 1986; 2: 119–123
   PubMed Web of Science ®Google Scholar
• The Canadian-European Randomized Control Trial Group. Cyclosporin-Induced Remission of IDDM after Early Intervention. Diabetes 1988; 37: 1574–82
   Google Scholar
• Silverstein J, Maclaren N, Riley W, Spillar R, Radjenovic D, Johnson S. Immunosuppression with Azathioprine and Prednisone in Recent-Onset Insulin-Dependent Diabetes Mellitus. N. Eng. J. Med. 1989; 319: 599–604
   Google Scholar
• Cook JJ, Hudson I, Harrison LC. A Double-Blind Controlled Trial of Azathioprine in Children with Newly-Diagnosed Type I Diabetes. Diabetes 1989; 38: 779–783
   PubMed Web of Science ®Google Scholar
• Shah SC, Malone JI, Simpson NE. A Randomized Trial of Intensive Insulin Therapy in Newly Diagnosed Insulin-Dependent Diabetes Mellitus. N. Eng. J. of Med. 1989; 320: 550–4
   PubMed Web of Science ®Google Scholar
• Perlman K, Ehrlich RM, Filler Rm, Albisser AM. Sustained Normoglycemia in Newly Diagnosed Type 1 Diabetic Subjects. Diabetes 1984; 33: 995–1001
   PubMed Web of Science ®Google Scholar
• De Beaufort CE, Houtzagers CMGJ, Braining GJ. Continuous Subcutaneous Insulin Infusion (CSII) Versus Conventional Injection Therapy in Newly Diagnosed Diabetic Children: Two-year Follow-up of a Randomized, Prospective Trial. Diab. Med. 1989; 6: 766–771
   Google Scholar
• Mirouze J, Selam JL, Pham TC, Mendoza E, Orsetti A. Sustained Insulin-Induced Remissions of Juvenile Diabetes by Means of an External Artificial Pancreas. Diabetologia 1978; 14: 224–227
   Google Scholar
• Boda M, Brucker F, Hironimus S, Fenichel P, Harter M. Interet de ľinsulinotherapie intensive interative systematique chez les diabetiques de type 1 en remission. Diabete Metab 1989; 15: 4
   Google Scholar
• Pinget M, Bickle JF, Anceau A, Audhuy B, Jacques C, Brogard JM, Dorner M. Juvenile Diabetes of Recent Onset Sustained Insulin Remission by Means of preprogrammed Insulin Infusion. Nouv. Presse Med. 1981; 10: 1381–84
   Google Scholar
• Nagy M, Chan E, Charles MA. Glipizide-Induced Immuno-modulation: Inhibition of Human Mononuclear Cell Stimulation and Macrophage Mediated Islet Cell Killing in the BB rat. Metabolism 1992; 41: 420–425
   Google Scholar
• Buschard K, Jorgensen M, Kjaer T, Bock T, Aaen K, Josefsen K. Reduction of Diabetes Incidence in BB rats by Neonatal Injections of Beta-Cell Stimulating Drugs. Diabetologia 1990; 33: A189
   Google Scholar
• Williams AJK, Beales PE, Krug J, Procaccini E, Signore A, Xu S, Gale EAM, Pozzilli P. Tolbutamide reduces the incidence of diabetes, but not insulitis, in the non-obese diabetic mouse. Diabetologia 1993; 36: 487–492
   Google Scholar
• Chan E, Hosszufaluzi N, Charles MA. The Use of Glipizide to Prevent Diabetes in the BB Rat. Diaetes 1991; 40: 116A
   Google Scholar
• Kolb H, Bach JF, Eisenbarth GS. 91989) Criteria for Immune Tials in Type 1 Diabetes. Lancet 1991; 2: 686
   Google Scholar
• Heding LG. Radioimmunological Determination of Human C-Peptide in Serum. Diabetologia 1975; 11: 541–548
   PubMed Web of Science ®Google Scholar
• Assan R, Feutren G, Sirmai J. Plasma C-Peptide Levels and Clinical Remissions in recent-Onset Type 1 Diabetic Patients Treated with Cyclosporin A and Insulin. Diabetes 1990; 39: 768–774
   PubMed Web of Science ®Google Scholar
• Bunn FJ, Shapiro R, McManus M, Garlick L, McDonald MJ, Gallop PM, Gabbay KH. Structural Heterogeneity of Human Hemoglobin A Due to Nonenzymatic Glycosylation. J. Bio. Chem. 1979; 254: 3892–2898
   PubMed Web of Science ®Google Scholar
• Monte M, Beuzard Y, Rosa J. Mapping of Several Abnormal Hemoglobins by Polyacrylamide Gel Isoelectric Focusing. Am. J. Clin. Path. 1976; 66: 753–759
   PubMed Web of Science ®Google Scholar
• Garlick RL, Mazer JS, Higgin PJ, Bunn HF. Characterization of Glycosylated Hemoglobins. J. Clin. Invest. 1983; 71: 1062–72
   PubMedGoogle Scholar
• Shienvold FL, Alejandro R, Larif Z, Mintz DJ. Human Pancreatic Cell Surface Antigens with Homologous Expression in Liver, Sweat Glands, and other Exocrine Tissue. Pancreas 1986; 1: 385–396
   Google Scholar
• Nathan DM, Rousell A, Godine JE. Glyburide or Insulin for Metabolic Control in Non-Insulin Dependent Diabetes Mellitus. Ann. Int. Med. 1988; 108: 334–340
   PubMedGoogle Scholar
• Selam JL, Brown S, Woertz L, Lozano J, Charles MA. The Association of Initial Blood Glucose Control and Induction of Remissions in New Onset Type 1 Diabetes. Nutrition and Metabolism 1991; 4: 313–317
   Google Scholar
• Bougneres PJ, Carel JC, Castano L. Factors Associated with Early Remission of Type I Diabetes in Children Treated with Cyclosporine. N. Eng. J. Med. 1988; 318: 663–670
   PubMed Web of Science ®Google Scholar
• Levy-Marchal C, Czernichow P. Cyclosporin A in Insulin-Dependent Diabetes Mellitus of Recent Onset:A Pilot Sutdy in Children. Hormone Res. 1988; 29: 177–184
   Google Scholar
• Imamura T, Koffler M, Helderman JH, Prince D, Thirlby R, Inman L, Unger Rh. Severe Diabetes Induced in Subtotally Depancreatized Dogs by Sustained Hyperglycemia. Diabetes 1988; 37: 600–609
   PubMed Web of Science ®Google Scholar
• Unger RJ, Grundy S. Hyperglycemia as an Inducer as Well as a Consequence of Impaired Islet Cell Function and Insulin Resistance: Implications for the Management of Diabetes. Diabetologia 1985; 28: 119–121
   PubMed Web of Science ®Google Scholar
• DeFronzo RA. The TriumvirATE: B-Cell, Muscle, A Collusion Responsible for NIDDM. Diabetes 1988; 37: 667–687
   PubMed Web of Science ®Google Scholar
• Mandrup-Poulsen T, Spinas GA, Prowse SJ. Islet Cytotoxicity of Interleukin 1 Influence of Culture Conditions and Islet Donor Characteristics. Diabetes 1987; 36: 641–647
   PubMed Web of Science ®Google Scholar
• Selam JL, Clot J, Andory M, Mirouze J. Circulatory Lymphocyte Subpopulations in Juvenile Insulin-Dependent Diabetics. Correction of Abnormalities by Adequate Blood Glucose Control. Diabetologia 1979; 16: 35–40
   Google Scholar
• Sanders R, Faro B, Stoler P, Mick GJ, McCormick KL. Adjunctive Use of Tolazamide in Newly-Diagnosed Diabetic Children. Horm. Metab. Res. 1990; 22: 576–580
   Google Scholar
• Madsbad S, Krarup T, Faber OK, Binder C, Regeur L. The Transient Effect of Strict Glycemic Control on B Cell Function in Newly Diagnosed Type I (Insulin Dependent) Diabetic patients. Diabetologia 1982; 22: 17–22
   Google Scholar
• Johannesen J, Helqvist S, Nerup J. Not All Secretagogues Sensitize Pancreatic Islets to Recombinant human Interleukin-1 Beta. Diabetologia 1990; 33: A19A
   Google Scholar
• Bougneres PF, Landais P, Boisson C. Limited Duration of Remission of Insulin Dependency in Children With Recent Overt Type 1 Diabetes Treated with Low-Dose Cyclosporin. Diabetes 1990; 39: 1264–1271
   PubMed Web of Science ®Google Scholar
• Teruya M, Takei S, Forrest L, Grunewald A, Chan E, Charles MA. Pancreatic Islet Function in Nondiabetic and Diabetic BB Rats. Diabetes 1993; 42: 1310–17
   Google Scholar